HSBC Holdings’s AbbVie ABBV Stock Holding History

HSBC Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.04M	Sell	27,900 -18,200	-39%	-$4.04M	﹤0.01%	1093
2025 Q4	$10.6M	Buy	+46,100	New	+$10.5M	0.01%	931
2025 Q3	–	Sell	-17,900	Closed	-$3.31M	–	2687
2025 Q2	$3.31M	Buy	+17,900	New	+$3.33M	﹤0.01%	1304
2024 Q4	–	Sell	-36,300	Closed	-$7.1M	–	3077
2024 Q3	$7.1M	Buy	36,300 +22,300	+159%	+$4.16M	﹤0.01%	1002
2024 Q2	$2.38M	Sell	14,000 -34,200	-71%	-$5.67M	﹤0.01%	1334
2024 Q1	$8.78M	Sell	48,200 -18,800	-28%	-$3.24M	0.01%	926
2023 Q4	$10.4M	Sell	67,000 -2,700	-4%	-$394K	0.01%	883
2023 Q3	$10.4M	Buy	69,700 +6,300	+10%	+$925K	0.01%	815
2023 Q2	$8.55M	Sell	63,400 -8,100	-11%	-$1.19M	0.01%	860
2023 Q1	$11.3M	Sell	71,500 -29,500	-29%	-$4.51M	0.01%	803
2022 Q4	$16.2M	Buy	101,000 +50,700	+101%	+$7.77M	0.02%	726
2022 Q3	$6.88M	Buy	50,300 +30,000	+148%	+$4.3M	0.01%	1053
2022 Q2	$3.12M	Sell	20,300 -45,700	-69%	-$6.98M	﹤0.01%	1381
2022 Q1	$10.8M	Buy	+66,000	New	+$9.59M	0.01%	852
2021 Q2	–	Sell	-35,100	Closed	-$3.82M	–	2913
2021 Q1	$3.82M	Buy	+35,100	New	+$3.75M	﹤0.01%	1112
2020 Q1	–	Sell	-107,500	Closed	-$9.46M	–	2655
2019 Q4	$9.46M	Sell	107,500 -596,600	-85%	-$49.5M	0.02%	846
2019 Q3	$53.3M	Buy	704,100 +207,000	+42%	+$14.2M	0.1%	209
2019 Q2	$36.1M	Buy	497,100 +158,000	+47%	+$12.4M	0.07%	294
2019 Q1	$27.3M	Sell	339,100 -35,500	-9%	-$2.9M	0.05%	386
2018 Q4	$34.5M	Buy	374,600 +149,700	+67%	+$13.2M	0.06%	312
2018 Q3	$21.3M	Sell	224,900 -39,200	-15%	-$3.72M	0.03%	527
2018 Q2	$24.5M	Sell	264,100 -92,500	-26%	-$9.03M	0.04%	424
2018 Q1	$33.8M	Buy	+356,600	New	+$39.2M	0.05%	363
2017 Q4	–	Sell	-684,500	Closed	-$60.8M	–	2022
2017 Q3	$60.8M	Buy	684,500 +135,800	+25%	+$10.3M	0.1%	182
2017 Q2	$39.8M	Buy	548,700 +4,000	+0.7%	+$269K	0.07%	268
2017 Q1	$35.5M	Sell	544,700 -414,200	-43%	-$26M	0.07%	278
2016 Q4	$60M	Buy	958,900 +481,400	+101%	+$29.4M	0.14%	151
2016 Q3	$30.1M	Sell	477,500 -43,400	-8%	-$2.81M	0.08%	306
2016 Q2	$32.2M	Buy	520,900 +288,900	+125%	+$17.6M	0.09%	264
2016 Q1	$13.3M	Sell	232,000 -88,600	-28%	-$4.94M	0.04%	536
2015 Q4	$19M	Buy	320,600 +156,400	+95%	+$9.01M	0.05%	468
2015 Q3	$8.93M	Sell	164,200 -106,800	-39%	-$6.95M	0.02%	636
2015 Q2	$18.2M	Buy	271,000 +190,000	+235%	+$12.4M	0.04%	444
2015 Q1	$4.74M	Sell	81,000 -96,000	-54%	-$5.8M	0.01%	923
2014 Q4	$11.6M	Buy	177,000 +88,600	+100%	+$5.59M	0.02%	612
2014 Q3	$5.11M	Buy	88,400 +44,900	+103%	+$2.49M	0.01%	867
2014 Q2	$2.46M	Buy	+43,500	New	+$2.28M	0.01%	1068

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HSBC Holdings's ABBV Position: Q1 2026 in Review

HSBC Holdings reduced its AbbVie (ABBV) stake by 5% in Q1 2026, selling an estimated $45.4M and leaving 3,860,492 shares worth $839M. The position accounts for 0.44% of the portfolio, ranked #34.

HSBC Holdings first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $930M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

HSBC Holdings held 3,860,492 shares of AbbVie worth $839M as of Q1 2026.
HSBC Holdings sold 204,488 AbbVie shares in Q1 2026, an estimated $45.4M.
AbbVie made up 0.44% of HSBC Holdings's portfolio in Q1 2026, its #34 holding.
HSBC Holdings first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's AbbVie position peaked at $930M in Q4 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.